Facebook Pixel

Comment Reply

EmpowHER Guest
Anonymous

The Canadian government approved Botox (Botulinum toxin type A) for the treatment of ophthalmic disorders associated with muscle overactivity such as misalignment of the eyes and contractions of the eyelids. Since then, it has also received approval to relieve a variety of conditions involving hyperactive muscles - most recently, cerebral palsy in children

April 29, 2009 - 7:16am

Reply

Image CAPTCHA
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy